What is the ticker symbol for Clearside Biomedical?

Clearside Biomedical trades under the ticker CLSD on NASDAQ.

What sector does Clearside Biomedical operate in?

Clearside Biomedical is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze CLSD in a portfolio?

PortView shows CLSD's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Clearside Biomedical (CLSD) Stock Analysis

NASDAQHealthcareBiotechnology

$0.41+0.00%

1-year price historyRange $0.27 – $15.45

52-week range$0.41

$0.31$17.10

What Clearside Biomedical does

Clearside Biomedical, Inc. is a biopharmaceutical company dedicated to pioneering novel drug delivery methods to the posterior segment of the eye via the suprachoroidal space. Its commercial product, XIPERE, is a triamcinolone acetonide suprachoroidal injectable suspension designed for treating uveitis macular edema. The company's development pipeline also features CLS-AX, an axitinib injectable suspension administered into the suprachoroidal space, which is currently undergoing Phase 1/2a clinical trials. Additionally, they are advancing CLS-301, an integrin inhibitor suspension aimed at addressing diabetic macular edema and macular degeneration. Clearside maintains strategic partnerships with Bausch Health, Arctic Vision, REGENXBIO, Inc., and Aura Biosciences. Established in 2011, Clearside Biomedical, Inc. is headquartered in Alpharetta, Georgia.

Key metrics

Market cap

$2.15M

P/E (TTM)

-0.18

EPS (TTM)

$-2.25

Beta

1.79

Dividend yield

0.00%

Revenue / share

$0.58

50-day avg

$2.87

200-day avg

$8.22

52-week high

$17.10

52-week low

$0.31

CEO

George Lasezkay

ETFs linked to CLSD

Broad-market and Healthcare sector ETFs an investor holding Clearside Biomedical is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how CLSD fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze CLSD in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Clearside Biomedical?: Clearside Biomedical trades under the ticker CLSD on NASDAQ.
Which exchange is CLSD listed on?: CLSD is listed on NASDAQ.
What sector does Clearside Biomedical operate in?: Clearside Biomedical is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze CLSD in a portfolio?: PortView shows CLSD's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.